Healthcare Global Enterprises Ltd

Health.Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Healthcare Global Enterprises Ltd

₹ 357 -1.73%
25 Apr - close price
hcgoncology.com BSE: 539787 NSE : HCG
About

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Key Points

Service Offering
The Company is a provider of specialty healthcare focused on cancer and fertility. Under the “HCG” brand, it operates the largest cancer care network in India in terms of the total number of private cancer treatment centers licensed by the AERB. It also provides fertility treatment under our “Milann” brand. [1]

Website BSE NSE
  • Market Cap ₹ 4,977 Cr.
  • Current Price ₹ 357
  • High / Low ₹ 401 / 260
  • Stock P/E 120
  • Book Value ₹ 84.6
  • Dividend Yield 0.00 %
  • ROCE 7.03 %
  • ROE 3.84 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's working capital requirements have reduced from 58.1 days to 38.7 days

Cons

  • Stock is trading at 4.22 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 11.4% over past five years.
  • Company has a low return on equity of 0.63% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
164.06 179.51 200.60 215.66 215.51 220.19 243.17 253.07 252.68 258.67 272.23 282.75 267.21
141.79 156.39 169.73 178.27 175.20 179.76 197.21 206.35 203.06 218.69 224.69 232.34 220.48
Operating Profit 22.27 23.12 30.87 37.39 40.31 40.43 45.96 46.72 49.62 39.98 47.54 50.41 46.73
OPM % 13.57% 12.88% 15.39% 17.34% 18.70% 18.36% 18.90% 18.46% 19.64% 15.46% 17.46% 17.83% 17.49%
-0.47 -139.75 4.53 126.96 -43.54 -24.75 1.87 1.27 2.10 0.56 1.83 2.13 5.52
Interest 14.00 12.78 12.50 10.35 10.73 9.22 9.72 11.67 10.53 9.57 9.69 10.98 13.21
Depreciation 21.63 21.25 20.97 21.30 23.90 22.19 21.70 22.40 21.81 23.06 21.64 23.28 24.09
Profit before tax -13.83 -150.66 1.93 132.70 -37.86 -15.73 16.41 13.92 19.38 7.91 18.04 18.28 14.95
Tax % 5.93% -1.70% 27.46% 29.24% -3.35% -13.92% 33.88% 20.98% 26.93% 47.16% 24.11% 25.05% 44.28%
-13.01 -153.22 1.40 93.90 -39.13 -17.92 10.85 11.00 14.16 4.18 13.69 13.70 8.33
EPS in Rs -1.04 -12.22 0.11 7.49 -2.82 -1.29 0.78 0.79 1.02 0.30 0.98 0.98 0.60
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
202 291 349 420 471 545 586 640 688 609 850 1,006 1,081
170 252 336 364 407 462 498 546 573 535 703 824 896
Operating Profit 32 39 13 56 64 83 88 94 116 74 147 181 185
OPM % 16% 14% 4% 13% 14% 15% 15% 15% 17% 12% 17% 18% 17%
3 2 3 0 -1 7 19 13 -19 -129 65 7 10
Interest 21 25 28 32 34 16 27 48 83 63 43 41 43
Depreciation 18 23 28 33 37 44 44 47 79 87 88 89 92
Profit before tax -4 -7 -40 -8 -9 29 37 13 -65 -205 81 58 59
Tax % -13% -9% 1% 69% 45% 34% 32% 42% 19% 7% 53% 30%
-4 -7 -40 -2 -5 19 25 7 -53 -192 38 40 40
EPS in Rs -0.67 -1.05 -5.79 -0.34 -0.56 2.27 2.86 0.82 -6.01 -15.28 2.75 2.89 2.86
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 13%
5 Years: 11%
3 Years: 13%
TTM: 12%
Compounded Profit Growth
10 Years: 24%
5 Years: 14%
3 Years: 58%
TTM: -1%
Stock Price CAGR
10 Years: %
5 Years: 12%
3 Years: 25%
1 Year: 34%
Return on Equity
10 Years: 0%
5 Years: 0%
3 Years: 1%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 59 67 68 70 85 86 87 88 89 125 139 139 139
Reserves 149 217 192 202 435 459 552 557 526 755 959 1,006 1,039
172 263 254 311 194 218 264 422 827 481 349 347 417
57 96 99 107 136 159 210 337 328 213 197 237 258
Total Liabilities 436 644 614 690 850 923 1,112 1,404 1,769 1,575 1,644 1,730 1,853
286 363 371 405 431 442 492 547 914 745 774 788 822
CWIP 3 1 10 28 29 33 79 104 44 28 5 9 12
Investments 31 138 80 84 155 141 219 299 316 366 439 475 506
116 142 152 173 235 306 322 454 495 436 426 458 512
Total Assets 436 644 614 690 850 923 1,112 1,404 1,769 1,575 1,644 1,730 1,853

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
7 24 34 51 58 54 66 87 86 71 124 130
-19 -180 -7 -74 -86 -73 -185 -208 -116 -246 49 -138
23 146 -19 22 120 -14 91 66 -3 236 -41 -42
Net Cash Flow 10 -10 8 -1 92 -33 -27 -55 -32 61 132 -49

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 74 73 54 56 54 67 79 83 81 88 69 77
Inventory Days 31 33 33 36 30 36 40 39 31 32 30 33
Days Payable 161 181 191 208 266 257 269 253 247 214 167 168
Cash Conversion Cycle -56 -75 -104 -116 -182 -154 -150 -131 -135 -94 -68 -59
Working Capital Days 39 9 -33 -39 -46 -41 -23 -54 -72 105 30 39
ROCE % 5% 4% -2% 5% 5% 6% 7% 6% 4% 1% 5% 7%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
68.41% 68.40% 71.44% 71.43% 71.42% 71.39% 71.39% 71.37% 71.35% 71.30% 71.29% 71.28%
6.42% 7.24% 7.03% 6.99% 7.22% 7.27% 7.18% 6.37% 6.47% 6.29% 6.37% 6.74%
9.69% 8.16% 6.59% 5.86% 4.55% 4.02% 4.41% 5.53% 6.58% 7.94% 8.46% 8.52%
15.48% 16.19% 14.94% 15.73% 16.81% 17.32% 17.04% 16.71% 15.59% 14.49% 13.89% 13.45%
No. of Shareholders 15,06520,57322,36223,66323,01824,67228,70728,85825,93127,32727,28927,195

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls